ZH
KR
JP
ES
RU
DEimmune cell migration
immune cell migration, Total:37 items.
In the international standard classification, immune cell migration involves: Medical equipment, Medical sciences and health care facilities in general, Pharmaceutics, Biology. Botany. Zoology, Vocabularies, Dentistry, Laboratory medicine, Quality.
Professional Standard - Medicine, immune cell migration
- YY/T 0606.20-2014 Tissue engineered medical products.Part 20: Standard practice for evaluation of immune responses of substrate and scaffold products :Cell migration tests
American Society for Testing and Materials (ASTM), immune cell migration
- ASTM F1906-98 Standard Practice for Evaluation of Immune Responses In Biocompatibility Testing Using ELISA Tests, Lymphocyte, Proliferation, and Cell Migration
- ASTM F1906-98(2003) Standard Practice for Evaluation of Immune Responses In Biocompatibility Testing Using ELISA Tests, Lymphocyte, Proliferation, and Cell Migration
Professional Standard - Agriculture, immune cell migration
- 1259藥典 化學(xué)藥和生物制品卷-2010 Chapter 17 Immunomodulatory Drugs 1. Immunosuppressive Drugs against Human T Cell Immunoglobulin
- 1258藥典 化學(xué)藥和生物制品卷-2010 Chapter 17 Immunomodulatory Drugs 1. Immunosuppressive Drugs Anti-Human T Cell CD3 Mouse Monoclonal Antibody
- 259藥典 三部-2010 Appendix Ⅹ XR Anti-human T cell immunoglobulin titer assay (lymphocytotoxicity test)
- 124藥典 三部-2020 Monograph Ⅱ Therapeutic anti-human T cell porcine immunoglobulin
- 125藥典 三部-2020 Monograph Ⅱ Therapeutic Anti-human T-cell Rabbit Immunoglobulins
- 113藥典 三部-2015 Monograph Ⅱ Therapeutic anti-human T cell porcine immunoglobulin
- 114藥典 三部-2015 Monograph Ⅱ Therapeutic Anti-human T-cell Rabbit Immunoglobulins
- 91藥典 三部-2010 Chapter Ⅱ Therapeutic anti-human T cell porcine immunoglobulin
- 92藥典 三部-2010 Chapter Ⅱ Therapeutic Anti-human T-cell Rabbit Immunoglobulin
- 1264藥典 化學(xué)藥和生物制品卷-2010 Chapter 17 Immunomodulatory Drugs 2. Immunoenhancing Drugs Pseudomonas
- 1252藥典 化學(xué)藥和生物制品卷-2010 Chapter 17 Immunomodulatory Drugs 1. Immunosuppressive Drugs Rat Anti-Human T Lymphocyte CD3 Antigen Monoclonal Antibody
- 327藥典 三部-2020 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test)
- 274藥典 四部-2020 3500 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test)
- 279藥典 四部-2015 3500 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test)
- 1269藥典 化學(xué)藥和生物制品卷-2010 Chapter 17 Immunomodulatory Drugs II. Immunoenhancing Drugs Polyinosinic Acid-Polycytidylic Acid
Group Standards of the People's Republic of China, immune cell migration
- T/CGCPU 010-2020 Environmental requirements for the preparation of immune cell products
- T/CGCPU 011-2020 Quality Control Requirements for Immune Cell Products
- T/SDHCST 008-2023 Procedures for Immunogenicity and Immunotoxicity of the Cell Therapy Medical Products
- T/CGCPU 009-2020 Control requirements for the preparation process of immune cell products
- T/ZSA 150-2023 Management requirements for donor materials of immune cell product
- T/CGCPU 019-2022 Material management requirements for immune cell product donors
- T/XSMIA 0004-2022 Quality Accreditation of Immunocyte Preparation Center
- T/CEAC 044-2024 Safety management specifications for the separation, preparation and storage of immune cells
- T/CGCPU 027-2023 Design specifications for clinical research protocol of immunotherapy
- T/CGCPU 028-2023 Requirements for quality control on non gene modified immune cells clinical research
- T/ZSA 146-2023 Technical requirements for Flow Cytometry validation of CD3、CD4、CD8 of immune cell product
- T/FDSA 0055-2024 Guidelines for the development of Cell immunotherapy products based on mRNA-LNP technology
- T/CGCPU 018-2022 Technical requirements for CD3, CD4, CD8 flow cytometric detection and verification of immune cell products
- T/GDMDMA 0001-2022 Interleukin 6 Detection kit (Chemiluminescent Immunoassay)
- T/CI 390-2024 The technical regulation for preparation and clinical application of immuno-cell CIK from healthy person
- T/SHPPA 019-2023 Guidance for the manufacturing quality management of plasmids used in the production of Immune cell therapy products
Hebei Provincial Standard of the People's Republic of China, immune cell migration
- DB13/T 5332-2021 Technical specification for clinical operation of cellular immunotherapy
Association Francaise de Normalisation, immune cell migration
- NF S91-146:1988 Dental implants. Cytocompatibility. Study of cellular multiplication, migration and adherence.
國家藥監(jiān)局, immune cell migration
- YY/T 1465.6-2019 Methods for evaluating the immunogenicity of medical devices Part 6: Determination of animal spleen lymphocyte subpopulations by flow cytometry